drugset / Trial / NCT03695822
Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome
NaSingle-groupOpen-labelTreatment
Summary
We will get the impact of mirabegron on psychological distress, urethra and bladder blood flow and c reactive protein.
Timeline
- Start
- 2018-12-24
- Primary completion
- 2019-01-21
- Completion
- 2019-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | 25 mg | — |